About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Combination of Multidrug-Resistant TB Bacteria Discovered

by Julia Samuel on January 10, 2018 at 3:07 PM
Font : A-A+

New Combination of Multidrug-Resistant TB Bacteria Discovered

The multidrug-resistant Mycobacterium tuberculosis was identified between February and November 2016, providing an impulse to launch a transnational investigation and developing a pan-European alerting system.

Resistant tuberculosis pathogens are a regular part of the day-to-day business at the Swiss National Center for Mycobacteria (NZM) at the University of Zurich. And yet, the Mycobacterium tuberculosis found in a Somali asylum seeker in the refugee center in Chiasso in February 2016 was extraordinary:

Advertisement


"These bacteria exhibited a new combination of resistance mutations against four different antibiotics that had never before been described," says Peter Keller, Head of Diagnostics at NZM, who identified the germ. The multidrug resistance makes it necessary for people carrying these bacteria to be isolated and undergo intravenous drug treatment at a hospital for several months.

In the months following the discovery, the same resistant germ was also observed in further patients, all of whom had migrated to Europe from countries on the Horn of Africa. In total, the NZM identified the pathogen in eight refugees from Somalia, Eritrea, and Djibouti between February and November 2016. Thanks to the rapid detection and the isolation measures, no further people were infected in Switzerland.
Advertisement

Alert issued and preventive measures

This unusual build-up prompted the management of NZM and of the Federal Office of Public Health (FOPH) to alert their colleagues across Europe. At the same time, the German reference laboratory in Borstel near Hamburg also registered a case with the same pathogen. The NZM then made their molecular-biological data available to the European Center for Disease Prevention and Control (ECDC) to enable their team to identify further possible cases in the EU.

In the course of these analyses, the European tuberculosis reference laboratories identified a total of 21 cases in a cross-border collaboration. As with the cases in Switzerland, these patients had also come from the Horn of Africa or Sudan.

Thanks to the alert, the pathogen was prevented from spreading further, and the authorities also took preventive measures: "The extraordinary case led to the development of a European alerting organization for dangerous tuberculosis pathogens," says Peter Keller, who initiated the European analyses. He is the corresponding author of the wide-reaching study, in which multiple European centers are involved.

Chain of infection reconstructed

Molecular-genetic analyses and interviews with patients made it possible for the researchers to partially reconstruct the chain of infection. The data indicate that the tuberculosis pathogen spread among migrants in a refugee camp near Bani Walid in Libya. The overcrowded camp, some 180 kilometers southeast of Tripoli, is notorious for its poor hygiene and inhumane conditions. Several of the patients diagnosed with this particular resistant Mycobacterium tuberculosis had come through this camp on their way to Europe.

Rapid test developed

It is no longer possible to identify with any degree of certainty the first carrier or who introduced the bacteria to the camp. Scientists believe that the pathogen originated in northern Somalia, where it is likely to have developed the dangerous new combination of resistances as a result of mutations. Genetic analyses have allowed researchers to develop a rapid PCR test. The test can be used in suspected cases of this Mycobacterium tuberculosis and the results are obtained in a matter of hours.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Goji Berries May Protect Against Age-Related Vision Loss
Tapping — A Proven Self-Applied Stress Intervention
Black Pepper as Preventive Measure Against Omicron
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Tuberculosis AIDS/HIV Shigellosis MRSA - The Super Bug Silicosis Screening Tests for Tuberculosis Food Safety for Health Antibiotics 

Recommended Reading
Screening Tests for Tuberculosis
Tuberculin skin test and Interferon - Release Assays are tests used to screen for tuberculosis....
Tuberculosis
Tuberculosis, caused by Mycobacterium tuberculosis, primarily affects the lung. It may spread to ......
Diet in Tuberculosis
Patients with tuberculosis should eat a healthy diet so that they build up their immunity to fight ....
Extra Pulmonary Tuberculosis
Extra pulmonary tuberculosis is infection of tissues and organs other than the lungs by ......
AIDS/HIV
"AIDS is an epidemic disease, a potentially preventable, deadly infection for which there is no cure...
Antibiotics
Antibiotics are among the most used and abused medications. This article explains some general featu...
MRSA - The Super Bug
MRSA infection is the most dreaded hospital or community acquired infection that can become ......
Shigellosis
Shigellosis or Bacillary Dysentery is a common cause of gastro-enteritis worldwide and can cause blo...
Silicosis
Silicosis is a lung disease caused by inhalation of crystalline free silica dust. It is characterise...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
ASK A DOCTOR ONLINE
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)